• Medscape InDiscussion: Obesity

  • 著者: Medscape
  • ポッドキャスト

Medscape InDiscussion: Obesity

著者: Medscape
  • サマリー

  • Join Dr Robert Kushner for Medscape InDiscussion: Obesity, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982630). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
    Copyright 2023, Medscape
    続きを読む 一部表示

あらすじ・解説

Join Dr Robert Kushner for Medscape InDiscussion: Obesity, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982630). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Copyright 2023, Medscape
エピソード
  • Obesity Rx: How to Use New Medications in Clinic
    2023/08/03

    Drs Robert Kushner and obesity pharmacotherapy expert Ania Jastreboff discuss how to use the new obesity medications effectively in clinic. Tune in to hear expert recommendations on patient communication, side effects, and more.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982636). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Obesity Treatment & Management https://emedicine.medscape.com/article/123702-treatment

    Drugs for Treating Obesity https://pubmed.ncbi.nlm.nih.gov/34783910/

    Control-Theory Models of Body-weight Regulation and Body-weight-regulatory Appetite https://pubmed.ncbi.nlm.nih.gov/31494154/

    Obesogenic Environments: Current Evidence of the Built and Food Environments https://pubmed.ncbi.nlm.nih.gov/28449616/

    FDA-approved Pharmacotherapy for Weight Loss Over the Last Decade https://pubmed.ncbi.nlm.nih.gov/36277516/

    Tirzepatide https://pubmed.ncbi.nlm.nih.gov/36251836/

    New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics https://pubmed.ncbi.nlm.nih.gov/36706749/

    Once-Weekly Semaglutide in Adults With Overweight or Obesity https://pubmed.ncbi.nlm.nih.gov/34192447/

    Tirzepatide Once Weekly for the Treatment of Obesity https://pubmed.ncbi.nlm.nih.gov/35658024/

    Bariatric Surgery https://emedicine.medscape.com/article/197081-overview

    FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014

    Body Mass Index https://medlineplus.gov/ency/article/007196.htm

    Descriptive Analysis of Reported Adverse Events Associated With Anti-obesity Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013-2020 https://pubmed.ncbi.nlm.nih.gov/34564826/

    Antiobesity Drug Therapy: An Individualized and Comprehensive Approach https://pubmed.ncbi.nlm.nih.gov/34341028/

    Barriers and Solutions for Prescribing Obesity Pharmacotherapy https://pubmed.ncbi.nlm.nih.gov/32418592/

    Addressing Insurance-related Barriers to Novel Antiobesity Medications: Lessons to Be Learned From Bariatric Surgery https://pubmed.ncbi.nlm.nih.gov/36190393/

    Certifying Physicians in the Treatment of Obesity https://www.abom.org/

    続きを読む 一部表示
    22 分
  • 'Diabesity' in Clinic: Prevention and Management
    2023/07/06

    Diabetes and obesity are on the rise, and there are new tools to help the prevention and management of this twin epidemic of "diabesity" in primary care. Drs Robert Kushner and Tim Garvey discuss.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982635). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Obesity Treatment & Management https://emedicine.medscape.com/article/123702-treatment

    Type 2 Diabetes Mellitus https://emedicine.medscape.com/article/117853-overview

    Diabesity https://diabetesjournals.org/clinical/article/40/4/392/147743/Diabesity

    National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States https://www.cdc.gov/diabetes/data/statistics-report/index.html

    Prevalence of Diabetes by Race and Ethnicity in the United States, 2011-2016 https://pubmed.ncbi.nlm.nih.gov/31860047/

    Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017 https://pubmed.ncbi.nlm.nih.gov/34427600/

    CDC Diabetes and Obesity Maps https://www.cdc.gov/diabetes/data/center/slides.html

    Diabetes Technology: Standards of Care in Diabetes – 2023 https://pubmed.ncbi.nlm.nih.gov/36507635/

    American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan – 2022 Update https://pubmed.ncbi.nlm.nih.gov/35963508/

    Mediterranean Diet and Obesity-Related Disorders: What Is the Evidence? https://pubmed.ncbi.nlm.nih.gov/36178601/

    The Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It https://pubmed.ncbi.nlm.nih.gov/16855180/

    Durability of a Primary Care–Led Weight-Management Intervention for Remission of Type 2 Diabetes: 2-Year Results of the DiRECT Open-Label, Cluster-Randomised Trial https://pubmed.ncbi.nlm.nih.gov/30852132/

    Semaglutide https://reference.medscape.com/drug/ozempic-rybelsus-wegovy-semaglutide-1000174

    Liraglutide https://reference.medscape.com/drug/victoza-saxenda-liraglutide-999449

    Tirzepatide Once Weekly for the Treatment of Obesity https://pubmed.ncbi.nlm.nih.gov/35658024/

    Glucagon-Like Peptide 1 Receptor Agonists https://www.ncbi.nlm.nih.gov/books/NBK551568/

    Dulaglutide Injection https://medlineplus.gov/druginfo/meds/a614047.html

    Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors https://www.ncbi.nlm.nih.gov/books/NBK576405/

    Incretin Hormones: Their Role in Health and Disease https://pubmed.ncbi.nlm.nih.gov/29364588/

    Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Antagonists as Anti-Diabetic Agents https://pubmed.ncbi.nlm.nih.gov/29412817/

    続きを読む 一部表示
    19 分
  • Medical Evaluation of the Patient Who Presents With Obesity
    2023/06/06

    How do you medically evaluate a person who presents with obesity? Drs Robert Kushner and Amanda Velazquez share practical tools and pearls for community clinicians.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982633). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Obesity Treatment & Management https://emedicine.medscape.com/article/123702-treatment

    A Primer on Smoking Cessation in Primary Care https://www.medscape.com/viewarticle/864524_3

    Reasons for Underutilization of Bariatric Surgery: The Role of Insurance Benefit Design https://pubmed.ncbi.nlm.nih.gov/30425002/

    Antiobesity Drug Therapy: An Individualized and Comprehensive Approach https://pubmed.ncbi.nlm.nih.gov/34341028/

    Taking a Weight History – Using Mnemonics to Learn a Missing Skill in Medical Education [Version 1] https://mededpublish.org/articles/6-215

    The Broadening Domain of the Metabolic Syndrome https://www.medscape.org/viewarticle/508282

    Mallampati Classification https://emedicine.medscape.com/article/2172419-overview

    Acanthosis Nigricans https://emedicine.medscape.com/article/1102488-overview

    Cushing's Syndrome https://www.niddk.nih.gov/health-information/endocrine-diseases/cushings-syndrome

    Clinical Use of the Edmonton Obesity Staging System for the Assessment of Weight Management Outcomes in People With Class 3 Obesity https://pubmed.ncbi.nlm.nih.gov/35267942/

    The Progression of Cardiometabolic Disease: Validation of a New Cardiometabolic Disease Staging System Applicable to Obesity https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866217/

    Modern Epigenetics Methods in Biological Research https://pubmed.ncbi.nlm.nih.gov/32645449/

    続きを読む 一部表示
    21 分

Medscape InDiscussion: Obesityに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。